微生物光谱研究揭示出BPD-9,一种来自黄麻的新化合物,有效针对抗药性微菌肺结核。 Study in Microbiology Spectrum reveals BPD-9, a new compound from sanguinarine, effectively targets drug-resistant Mycobacterium tuberculosis.
一项对 * 微生物谱* 的研究揭示出BPD-9,这是一种来自血清的新型半合成化合物,有效针对的是包括抗药菌株在内的麦昆菌肺结核。 A study in *Microbiology Spectrum* reveals BPD-9, a new semi-synthetic compound from sanguinarine, that effectively targets Mycobacterium tuberculosis, including drug-resistant strains. 它显示出对休眠细菌和细胞内细菌的希望,这些细菌对目前的肺结核治疗提出了挑战。 It shows promise against dormant and intracellular bacteria, which challenge current TB treatments. BPD-9还可能有助于防治非结核病性脑细胞感染,突出其临床使用潜力和对抗生素抗药性的进一步研究。 BPD-9 may also aid in fighting non-tuberculous mycobacterial infections, highlighting its potential for clinical use and further research in antibiotic resistance.